STAT-Dx Seals CE-IVD Mark For POC Syndromic Testing System

STAT-Dx has sealed a CE-IVD mark for its point-of-care syndromic testing system and a respiratory panel. The firm will launch the system in Europe in the second half of 2018.

Diagnostics start-up STAT-Dx has sealed CE approval for its syndromic testing platform DiagCORE and the first assay, the DiagCORE Respiratory Panel 1, based on results of evaluation trials that will be presented at the European Congress of Clinical Microbiology and Infectious Diseases conference in Madrid in late April.

STAT-Dx's DiagCORE point-of-care platform is designed to test for the presence or absence of multiple pathogens that may cause clinical...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from In Vitro Diagnostics

More from Diagnostics